Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells
- PMID: 14739224
- DOI: 10.1182/blood-2003-09-3335
Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells
Abstract
Acute myeloid leukemia (AML) is characterized by the block of differentiation, deregulated apoptosis, and an increased self-renewal of hematopoietic precursors. It is unclear whether the self-renewal of leukemic blasts results from the cumulative effects of blocked differentiation and impaired apoptosis or whether there are mechanisms directly increasing self-renewal. The AML-associated translocation products (AATPs) promyelocytic leukemia/retinoic acid receptor alpha (PML/RAR alpha), promyelocytic leukemia zinc finger (PLZF)/RAR alpha (X-RAR alpha), and AML-1/ETO block hematopoietic differentiation. The AATPs activate the Wnt signaling by up-regulating gamma-catenin. Activation of the Wnt signaling augments self-renewal of hematopoietic stem cells (HSCs). Therefore, we investigated how AATPs influence self-renewal of HSCs and evaluated the role of gamma-catenin in the determination of the phenotype of HSCs expressing AATPs. Here we show that the AATPs directly activate the gamma-catenin promoter. The crucial role of gamma-catenin in increasing the self-renewal of HSCs upon expression of AATPs is demonstrated by (i) the abrogation of replating efficiency upon hindrance of gamma-catenin expression through RNA interference, and (ii) the augmentation of replating efficiency of HSCs upon overexpression of gamma-catenin itself. In addition, the inoculation of gamma-catenin-transduced HSCs into irradiated recipient mice establishes the clinical picture of AML. These data provide the first evidence that the aberrant activation of Wnt signaling by the AATP decisively contributes to the pathogenesis of AML.
Similar articles
-
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.Mol Cell Biol. 2004 Apr;24(7):2890-904. doi: 10.1128/MCB.24.7.2890-2904.2004. Mol Cell Biol. 2004. PMID: 15024077 Free PMC article.
-
Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.PLoS One. 2011;6(7):e22540. doi: 10.1371/journal.pone.0022540. Epub 2011 Jul 19. PLoS One. 2011. PMID: 21811629 Free PMC article.
-
Cooperation between constitutively activated c-Kit signaling and leukemogenic transcription factors in the determination of the leukemic phenotype in murine hematopoietic stem cells.Int J Oncol. 2009 Jun;34(6):1521-31. doi: 10.3892/ijo_00000281. Int J Oncol. 2009. PMID: 19424569
-
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.Curr Top Microbiol Immunol. 1997;220:81-112. doi: 10.1007/978-3-642-60479-9_6. Curr Top Microbiol Immunol. 1997. PMID: 9103677 Review.
-
The molecular genetics of acute promyelocytic leukemia.Blood Rev. 1993 Jun;7(2):87-93. doi: 10.1016/s0268-960x(05)80018-9. Blood Rev. 1993. PMID: 8396481 Review.
Cited by
-
The interplay of autophagy and β-Catenin signaling regulates differentiation in acute myeloid leukemia.Cell Death Discov. 2015 Sep 21;1:15031. doi: 10.1038/cddiscovery.2015.31. eCollection 2015. Cell Death Discov. 2015. PMID: 27551462 Free PMC article.
-
Wnt Signalling in Acute Myeloid Leukaemia.Cells. 2019 Nov 7;8(11):1403. doi: 10.3390/cells8111403. Cells. 2019. PMID: 31703382 Free PMC article. Review.
-
_targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives.Biosci Rep. 2022 Apr 29;42(4):BSR20211841. doi: 10.1042/BSR20211841. Biosci Rep. 2022. PMID: 35352805 Free PMC article. Review.
-
PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.Leukemia. 2009 Aug;23(8):1462-71. doi: 10.1038/leu.2009.63. Epub 2009 Mar 26. Leukemia. 2009. PMID: 19322209 Free PMC article.
-
Role of RUNX1 in hematological malignancies.Blood. 2017 Apr 13;129(15):2070-2082. doi: 10.1182/blood-2016-10-687830. Epub 2017 Feb 8. Blood. 2017. PMID: 28179279 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous